A generic strategy for pharmacological caging of growth factors for tissue engineering.

The caging of small molecules has revolutionized biological research by providing a means to regulate a wide range of processes. Here we report on a generic pharmacological method to cage proteins in a similar fashion. The present approach is of value in both fundamental and applied research, e.g. in tissue engineering.

[1]  H. Ball,et al.  Manipulating Cell Migration and Proliferation with a Light‐Activated Polypeptide , 2009, Chembiochem : a European journal of chemical biology.

[2]  Margaret J. Robertson,et al.  Design and Analysis of Experiments , 2006, Handbook of statistics.

[3]  G. Hong,et al.  Nucleic Acids Research , 2015, Nucleic Acids Research.

[4]  M. Yaffe,et al.  Caged phosphopeptides reveal a temporal role for 14-3-3 in G1 arrest and S-phase checkpoint function , 2004, Nature Biotechnology.

[5]  Shaheynoor Talukder,et al.  Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo , 2010, The EMBO journal.

[6]  K. Ueki,et al.  Insulin Receptor Substrate 3 (IRS-3) and IRS-4 Impair IRS-1- and IRS-2-Mediated Signaling , 2001, Molecular and Cellular Biology.

[7]  Matthias P Lutolf,et al.  Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions. , 2007, Biomacromolecules.

[8]  L. Allen.  Stem cells. , 2003, The New England journal of medicine.

[9]  Martin Fussenegger,et al.  A Gene Therapy Technology‐Based Biomaterial for the Trigger‐Inducible Release of Biopharmaceuticals in Mice , 2010 .

[10]  M. Lutolf,et al.  Artificial niche microarrays for probing single stem cell fate in high throughput , 2011, Nature Methods.

[11]  Yasushi Miyashita,et al.  Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons , 2001, Nature Neuroscience.

[12]  L C Chesley,et al.  American Journal of Obstetrics and Gynecology, Volume 124, 1976: The remote prognosis of eclamptic women. Sixth periodic report. , 2000, American journal of obstetrics and gynecology.

[13]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  K. Tanonaka,et al.  Effects of tanshinone VI on phosphorylation of ERK and Akt in isolated cardiomyocytes and cardiac fibroblasts. , 2008, European journal of pharmacology.

[15]  George J. Augustine,et al.  Local calcium signalling by inositol-1,4,5-trisphosphate in Purkinje cell dendrites , 1998, Nature.

[16]  Harrison H Barrett,et al.  Mesenchymal Stem Cell‐Mediated Delivery of the Sodium Iodide Symporter Supports Radionuclide Imaging and Treatment of Breast Cancer , 2011, Stem cells.

[17]  Zhifeng Shao,et al.  Fc-fusion proteins: new developments and future perspectives , 2012, EMBO molecular medicine.

[18]  J. Kaplan,et al.  Rapid photolytic release of adenosine 5'-triphosphate from a protected analogue: utilization by the Na:K pump of human red blood cell ghosts. , 1978, Biochemistry.

[19]  M. Andreeff,et al.  Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells , 2008, Gene Therapy.

[20]  M. O’Banion,et al.  Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling , 2014, Oncogene.

[21]  Victor H Hernandez,et al.  Nature Methods , 2007 .

[22]  Y. E. Goldman,et al.  Kinetics of smooth and skeletal muscle activation by laser pulse photolysis of caged inositol 1,4,5-trisphosphate , 1987, Nature.

[23]  G. P. Reid,et al.  Photolabile 1-(2-nitrophenyl)ethyl phosphate esters of adenine nucleotide analogs. Synthesis and mechanism of photolysis , 1988 .

[24]  References , 1971 .

[25]  M. Kerin,et al.  Advances in mesenchymal stem cell-mediated gene therapy for cancer , 2010, Stem Cell Research & Therapy.

[26]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[27]  P. Lawrence,et al.  Genes in development , 1977, Nature.

[28]  W. Marsden.  I and J , 2012 .

[29]  E. Hall,et al.  The nature of biotechnology. , 1988, Journal of biomedical engineering.

[30]  M. Andreeff,et al.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.